Amanote Research
Register
Sign In
Substituting Adjuvant Trastuzumab Emtansine for Herceptin Improves Survival in Patients With Human Epidermal Growth Factor Receptor 2–positive Breast Cancer
Cancer
- United States
doi 10.1002/cncr.32088
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
April 1, 2019
Authors
Carrie Printz
Publisher
Wiley